Key Highlights
- IonQ submitted an SEC prospectus enabling the University of Cambridge to resell 2,562,642 shares of common stock.
- The SEC submission stems from a Registration Rights Agreement executed this Tuesday between IonQ and Cambridge.
- In parallel news, IonQ revealed plans for establishing the IonQ Quantum Innovation Centre at Cambridge’s campus.
- The collaboration involves installing IonQ’s 256-qubit quantum system at Cambridge with shared intellectual property rights.
- IONQ shares show a 21.7% decline year-to-date while posting an 87.8% gain over the trailing year, currently priced at $35.12.
IonQ submitted a supplemental prospectus to the Securities and Exchange Commission this Wednesday, registering 2,562,642 common shares for potential resale by the University of Cambridge.
These shares were initially distributed through a private offering utilizing Section 4(a)(2) of the Securities Act of 1933 and/or Rule 506 of Regulation D — commonly employed exemptions for private placement transactions.
The prospectus follows a Registration Rights Agreement executed this Tuesday between IonQ and the University of Cambridge. This agreement grants Cambridge authorization to divest these shares through public markets.
Paul, Weiss, Rifkind, Wharton & Garrison LLP furnished the legal counsel for this filing.
IONQ stock showed modest gains during Wednesday’s premarket session. Shares are currently trading at $35.12, giving IonQ a market capitalization of approximately $12.88 billion.
The equity has experienced challenges entering 2026, declining 21.7% year-to-date. However, the stock demonstrates stronger performance over the past year, advancing 87.8%.
The share registration wasn’t IonQ’s only announcement on Wednesday.
Cambridge to Host IonQ Quantum Innovation Centre
The quantum computing firm simultaneously disclosed a partnership with the University of Cambridge for creating the IonQ Quantum Innovation Centre at the university.
The arrangement provides Cambridge with IonQ’s sixth-generation, chip-based quantum system featuring 256 qubits on its campus facilities. The university will additionally gain access to IonQ’s cloud-based quantum platform.
The partnership encompasses collaborative research and development initiatives spanning quantum computing, networking, sensing, and security technologies. A shared licensing framework for any intellectual property generated through the collaboration is also included.
“This historic agreement with Cambridge deepens IonQ’s commitment to the United Kingdom,” said CEO Niccolo de Masi. “By establishing the IonQ Quantum Innovation Center, we are strengthening the bridge between academic discovery and commercial quantum advantage.”
Wall Street Perspective on IONQ
This marks IonQ’s second recent prospectus supplement filing. The company had previously filed documentation covering resale rights for more than 5.1 million common shares.
Regarding analyst coverage, Benchmark recently adjusted its price objective for IonQ downward to $65, expressing concerns regarding revenue composition — while maintaining its Buy recommendation. The firm highlighted that IonQ’s primary computing division expanded more than 80% year-over-year.
Morgan Stanley elevated its price target to $37, sustaining an Equalweight stance. The investment bank emphasized robust organic and acquisition-driven expansion.
IonQ also recently entered a partnership with the Applied Research Laboratory for Intelligence and Security focused on quantum computing security initiatives. This program receives sponsorship from the Secretary of the Air Force’s Concepts, Development, and Management Office.
IONQ stock is listed on the New York Stock Exchange under ticker symbol IONQ


